Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken(Antwerp University Hospital), Jan Stöhlmacher-Williams(University Hospital Carl Gustav Carus), Ірина Давиденко(Krasnodar Research Institute of Storage and Processing of Agricultural Products), Lisa Licitra(Fondazione IRCCS Istituto Nazionale dei Tumori), Eric Winquist(London Health Sciences Centre), Cristian Villanueva(Centre Hospitalier Universitaire de Besançon), Paolo Foa(Ospedale San Paolo), Sylvie Rottey(Ghent University Hospital), Krzysztof Składowski, Makoto Tahara(National Cancer Center Hospital East), Vasant R. Pai(Tata Memorial Hospital), Sandrine Faivre(Hôpital Beaujon), C. Blajman, Arlene A. Forastiere(Johns Hopkins University), B. Stein(Centre for Cancer Biology), Kelly S. Oliner(Amgen (United States)), Zhiying Pan(Amgen (United States)), Bruce Allen Bach(Amgen (United States))
Cited by 433Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis